Eldor M. Mirkomilov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eldor M. Mirkomilov has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Erkin N. Bilalov
Tashkent Medical Academy
3 shared publications - Okilkhon I. Oripov
Tashkent Medical Academy
2 shared publications - Rustam A. Zakirkhodjaev
Tashkent Medical Academy
2 shared publications - B. E. Bilalov
Tashkent Medical Academy
1 shared publication Rahbarali Sh. Makhmudov
Tashkent State Medical Universuty
1 shared publication- К. И. Нарзикулова
Tashkent Medical Academy
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Springer Nature in Research Square
Diagnostic Value of Anterior Segment Optical Coherence Tomography-Derived Schlemm's Canal Morphometry for Detecting Ocular Hypertension in Thyroid Eye Disease
Purpose. To evaluate morphometric alterations of Schlemm's canal (SC) using anterior segment optical coherence tomography (AS-OCT), investigate their relationship with ocular hydrodynamic parameters, and determine their diagnostic value for detecting ocular hypertension in patients with thyroid eye disease (TED). Methods. This cross-sectional study included 150 eyes of 150 participants divided into four groups: patients with TED and ocular hypertension (Group A, n=38), TED without ocular hypertension (Group B, n=40), primary open-angle glaucoma (POAG; Group C, n=36), and healthy controls (Group D, n=36). All participants underwent comprehensive ophthalmic examination, including Goldmann applanation tonometry, Hertel exophthalmometry, retinal optical coherence tomography, Nesterov electronic tonography, and AS-OCT imaging of Schlemm's canal. Schlemm's canal length and cross-sectional area were quantified using ImageJ software. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of SC morphometric parameters for identifying ocular hypertension. Results. Patients with TED and ocular hypertension demonstrated significantly reduced Schlemm's canal length (258.3±10.1 μm) and cross-sectional area (4606±139 μm²) compared with patients with POAG and healthy controls (p<0.05). Electronic tonography revealed significantly higher true intraocular pressure and Becker coefficient together with reduced aqueous humor outflow facility in this group. ROC analysis showed that the SC cross-sectional area demonstrated excellent diagnostic performance for detecting ocular hypertension (AUC=0.937; 95% CI: 0.858-0.980), with an optimal cutoff value of ≤4860 μm², yielding 100.0% sensitivity and 75.0% specificity. In comparison, SC length demonstrated only moderate diagnostic performance (AUC=0.685; 95% CI: 0.569-0-0.785). Conclusions. Thyroid eye disease complicated by ocular hypertension is associated with significant structural remodeling of Schlemm's canal and impaired ocular hydrodynamics. Among the evaluated morphometric parameters, the SC cross-sectional area demonstrated superior diagnostic performance and may serve as a promising non-invasive imaging biomarker for early identification of ocular hypertension in patients with thyroid eye disease.
- 30 June 2026
- Published by Springer Nature in Research Square
Open AccessDiagnostic Value of Anterior Segment Optical Coherence Tomography-Derived Schlemm's Canal Morphometry for Detecting Ocular Hypertension in Thyroid Eye Disease
Purpose. To evaluate morphometric alterations of Schlemm's canal (SC) using anterior segment optical coherence tomography (AS-OCT), investigate their relationship with ocular hydrodynamic parameters, and determine their diagnostic value for detecting ocular hypertension in patients with thyroid eye disease (TED). Methods. This cross-sectional study included 150 eyes of 150 participants divided into four groups: patients with TED and ocular hypertension (Group A, n=38), TED without ocular hypertension (Group B, n=40), primary open-angle glaucoma (POAG; Group C, n=36), and healthy controls (Group D, n=36). All participants underwent comprehensive ophthalmic examination, including Goldmann applanation tonometry, Hertel exophthalmometry, retinal optical coherence tomography, Nesterov electronic tonography, and AS-OCT imaging of Schlemm's canal. Schlemm's canal length and cross-sectional area were quantified using ImageJ software. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of SC morphometric parameters for identifying ocular hypertension. Results. Patients with TED and ocular hypertension demonstrated significantly reduced Schlemm's canal length (258.3±10.1 μm) and cross-sectional area (4606±139 μm²) compared with patients with POAG and healthy controls (p<0.05). Electronic tonography revealed significantly higher true intraocular pressure and Becker coefficient together with reduced aqueous humor outflow facility in this group. ROC analysis showed that the SC cross-sectional area demonstrated excellent diagnostic performance for detecting ocular hypertension (AUC=0.937; 95% CI: 0.858-0.980), with an optimal cutoff value of ≤4860 μm², yielding 100.0% sensitivity and 75.0% specificity. In comparison, SC length demonstrated only moderate diagnostic performance (AUC=0.685; 95% CI: 0.569-0-0.785). Conclusions. Thyroid eye disease complicated by ocular hypertension is associated with significant structural remodeling of Schlemm's canal and impaired ocular hydrodynamics. Among the evaluated morphometric parameters, the SC cross-sectional area demonstrated superior diagnostic performance and may serve as a promising non-invasive imaging biomarker for early identification of ocular hypertension in patients with thyroid eye disease.
- Open Access
- 6 November 2025
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 14 (3) , 55-62
ДИФФЕРЕНЦИРОВАННАЯ СТРАТЕГИЯ НАБЛЮДЕНИЯ И ТЕРАПИИ ПРИ ОФТАЛЬМОГИПЕРТЕНЗИИ НА ФОНЕ ЭНДОКРИННОЙ ОФТАЛЬМОПАТИИ
Relevance. The combination of endocrine ophthalmopathy (EO) with ocular hypertension (OHT) and glaucoma presents a diagnostically and therapeutically complex clinical scenario. In the absence of a unified management strategy, there is a high risk of delayed detection of glaucomatous changes and irreversible visual loss. Purpose of the study. To evaluate the clinical course of OHT and glaucoma in patients with EO and to develop an optimal management strategy based on clinical-functional and morphological parameters. Materials and methods. A total of 38 eyes of patients with EO and elevated intraocular pressure were examined. The assessment included tonometry, anterior segment OCT, analysis of Schlemm’s canal, retinal nerve fiber layer (RNFL) thickness measurement, and computer perimetry. Patient management was based on a developed clinical algorithm. Treatment effectiveness was evaluated by monitoring changes in Visual Field Index (VFI) and Mean Deviation (MD) over a two-year period. Results and conclusion. Complete stabilization of functional parameters was achieved in 100% of eyes with confirmed glaucoma and in 87.5% of eyes with OHT without signs of glaucoma. In 12.5% of cases, disease progression and transition to glaucomatous pathology were observed, requiring the initiation of therapy. An individualized approach with regular structural and functional monitoring enables effective control of OHT progression and early detection of glaucomatous damage in patients with EO.
- 6 November 2025
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 14 (3) , 55-62
Open AccessДИФФЕРЕНЦИРОВАННАЯ СТРАТЕГИЯ НАБЛЮДЕНИЯ И ТЕРАПИИ ПРИ ОФТАЛЬМОГИПЕРТЕНЗИИ НА ФОНЕ ЭНДОКРИННОЙ ОФТАЛЬМОПАТИИ
Relevance. The combination of endocrine ophthalmopathy (EO) with ocular hypertension (OHT) and glaucoma presents a diagnostically and therapeutically complex clinical scenario. In the absence of a unified management strategy, there is a high risk of delayed detection of glaucomatous changes and irreversible visual loss. Purpose of the study. To evaluate the clinical course of OHT and glaucoma in patients with EO and to develop an optimal management strategy based on clinical-functional and morphological parameters. Materials and methods. A total of 38 eyes of patients with EO and elevated intraocular pressure were examined. The assessment included tonometry, anterior segment OCT, analysis of Schlemm’s canal, retinal nerve fiber layer (RNFL) thickness measurement, and computer perimetry. Patient management was based on a developed clinical algorithm. Treatment effectiveness was evaluated by monitoring changes in Visual Field Index (VFI) and Mean Deviation (MD) over a two-year period. Results and conclusion. Complete stabilization of functional parameters was achieved in 100% of eyes with confirmed glaucoma and in 87.5% of eyes with OHT without signs of glaucoma. In 12.5% of cases, disease progression and transition to glaucomatous pathology were observed, requiring the initiation of therapy. An individualized approach with regular structural and functional monitoring enables effective control of OHT progression and early detection of glaucomatous damage in patients with EO.
- Open Access
- 21 May 2025
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 11 (5) , 11-14
СОПОСТАВЛЕНИЕ КОНЦЕНТРАЦИЙ МОЗГОВОГО НЕЙРОТРОФИЧЕСКОГО ФАКТОРА В СЛЕЗНОЙ ЖИДКОСТИ И ПЛАЗМЕ КРОВИ ПРИ БОЛЕЗНИ ТАКАЯСУ И АТЕРОСКЛЕРОЗЕ
Relevance. Takayasu disease (TD) is a systemic inflammatory disease characterized by the involvement of large arteries, primarily the aorta and its branches, and, less frequently, the pulmonary arteries. Purpose of the study.This study presents a comparative analysis of brain-derived neurotrophic factor (BDNF) levels in tear fluid and blood serum in patients with Takayasu disease and carotid artery atherosclerosis. Material and methods. A total of 38 patients were examined, divided into three groups: 15 patients with nonspecific aortoarteriitis (TD), 13 patients with carotid artery atherosclerosis, and 10 healthy individuals. Results. The results showed that BDNF levels in tear fluid and blood serum in patients with Takayasu disease were significantly higher compared to other groups. Conclusion. The data suggest that elevated BDNF levels may serve as an early diagnostic marker for TD, as well as an indicator of the development of ischemic processes, requiring timely diagnosis and treatment.
- 21 May 2025
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 11 (5) , 11-14
Open AccessСОПОСТАВЛЕНИЕ КОНЦЕНТРАЦИЙ МОЗГОВОГО НЕЙРОТРОФИЧЕСКОГО ФАКТОРА В СЛЕЗНОЙ ЖИДКОСТИ И ПЛАЗМЕ КРОВИ ПРИ БОЛЕЗНИ ТАКАЯСУ И АТЕРОСКЛЕРОЗЕ
Relevance. Takayasu disease (TD) is a systemic inflammatory disease characterized by the involvement of large arteries, primarily the aorta and its branches, and, less frequently, the pulmonary arteries. Purpose of the study.This study presents a comparative analysis of brain-derived neurotrophic factor (BDNF) levels in tear fluid and blood serum in patients with Takayasu disease and carotid artery atherosclerosis. Material and methods. A total of 38 patients were examined, divided into three groups: 15 patients with nonspecific aortoarteriitis (TD), 13 patients with carotid artery atherosclerosis, and 10 healthy individuals. Results. The results showed that BDNF levels in tear fluid and blood serum in patients with Takayasu disease were significantly higher compared to other groups. Conclusion. The data suggest that elevated BDNF levels may serve as an early diagnostic marker for TD, as well as an indicator of the development of ischemic processes, requiring timely diagnosis and treatment.
- Open Access
- 22 February 2023
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 1 (1) , 28-31
ОСОБЕННОСТИ КРОВООБРАЩЕНИЯ ОРГАНА ЗРЕНИЯ ПРИ БОЛЕЗНИ ТАКАЯСУ
Purpose of this study.To study the features of the blood circulation of the organ of vision in Takayasu’s disease (TD). Material and methods. 50 patients with TD with lesions of brachiocephalic vessels were examined. All patients underwent general ophthalmological examinations, duplex scanning of the brachiocephalic arteries (BCA) and ophthalmic dopplerography. Results. Ophthalmoscopy revealed that 39 (78%) patients had narrowing of the retinal arteries, 40 (80,1%) patients had retinal vein enlargement, retinal haemorrhages in 20 (40%), disc neovascularization in 12 (24,1%) and cotton-wool lesions — in 7 (14%) patients. Duplex scanning of the vessels of the eyeball revealed that ischemia of the organ of vision on the side of the lesion of the brachycephalic vessels is not determined in all cases. Collateral circulation is compensated by stealing blood from the unaffected side. Conclusion. In Takayasu’s disease, 76% of patients, despite pronounced changes in the brachiocephalic vessels, the functional parameters of the eyeball remained within the normal range, which indicates the possible influence of other compensatory mechanisms during ischemia.
- 22 February 2023
- Published by Scientific Innovations in Advanced Ophthalmology
- Vol. 1 (1) , 28-31
Open AccessОСОБЕННОСТИ КРОВООБРАЩЕНИЯ ОРГАНА ЗРЕНИЯ ПРИ БОЛЕЗНИ ТАКАЯСУ
Purpose of this study.To study the features of the blood circulation of the organ of vision in Takayasu’s disease (TD). Material and methods. 50 patients with TD with lesions of brachiocephalic vessels were examined. All patients underwent general ophthalmological examinations, duplex scanning of the brachiocephalic arteries (BCA) and ophthalmic dopplerography. Results. Ophthalmoscopy revealed that 39 (78%) patients had narrowing of the retinal arteries, 40 (80,1%) patients had retinal vein enlargement, retinal haemorrhages in 20 (40%), disc neovascularization in 12 (24,1%) and cotton-wool lesions — in 7 (14%) patients. Duplex scanning of the vessels of the eyeball revealed that ischemia of the organ of vision on the side of the lesion of the brachycephalic vessels is not determined in all cases. Collateral circulation is compensated by stealing blood from the unaffected side. Conclusion. In Takayasu’s disease, 76% of patients, despite pronounced changes in the brachiocephalic vessels, the functional parameters of the eyeball remained within the normal range, which indicates the possible influence of other compensatory mechanisms during ischemia.